Skip to main content
Erica Rogers, MD, Dermatology, Pleasanton, CA

EricaJeanRogersMD

Dermatology Pleasanton, CA

Physician

Dr. Rogers is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rogers' full profile

Already have an account?

  • Office

    7601 Stoneridge Drive
    South building Dermatology
    Pleasanton, CA 94588
    Phone+1 925-847-5090

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Dermatology, 2005 - 2008
  • Mercy Hospital (St Louis)
    Mercy Hospital (St Louis)Internship, Transitional Year, 2004 - 2005
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 2004

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2015 - 2026
  • IL State Medical License
    IL State Medical License 2007 - 2017
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2011-2013
  • Fellow (FAAD) American Academy of Dermatology
  • Fellow (FASDS) American Society for Dermatologic Surgery

Publications & Presentations

PubMed

Press Mentions

  • Silk Road Medical Announces First Patient Enrolled in ROADSTER 3 Post Approval Study Evaluating TCAR® System in the Treatment of Standard Surgical Risk Patients
    Silk Road Medical Announces First Patient Enrolled in ROADSTER 3 Post Approval Study Evaluating TCAR® System in the Treatment of Standard Surgical Risk PatientsSeptember 7th, 2022
  • Silk Road Medical Announces Post Approval Study for the Treatment of Standard Surgical Risk Patients Using TCAR
    Silk Road Medical Announces Post Approval Study for the Treatment of Standard Surgical Risk Patients Using TCARJune 15th, 2022
  • First Ever Analysis of TCAR in Standard Surgical Risk Patients Demonstrates Clinical Benefits in Large Comparative Dataset
    First Ever Analysis of TCAR in Standard Surgical Risk Patients Demonstrates Clinical Benefits in Large Comparative DatasetAugust 18th, 2021
  • Join now to see all

Professional Memberships